niet- aangeboren hersenletsel Glaucoma POAG. Acquired brain injury
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Participant without vision loss (control participant; experiment O, A1) -18 years or older. • Informed written consent Participant with Glaucoma (experiment A2): •Diagnosed with glaucoma •Reliable SAP (based on most recent SAP assessment, information in their medical file). •Age 50-70 •No cognitive impairments (MoCa score: score >= 24; TOSSA screening test score > 5th percentile) •Informed written consent Participant with ABI (experiment A3): •Diagnosed with acquired brain injury •Cognitive impairment (CI), based on test scores regular care UMCG. •Age:18-70 •Informed written consent. Participant with ABI (experiment A4): •Diagnosed with acquired brain injury •Age 50-70 •Informed written consent.
Exclusion criteria
Exclusion criteria: Any of the following criteria will lead to exclusion from participation: Participant without vision loss (healthy control participant; experiment O, A1) •eye disease •family history of glaucoma •neurological disorder •cognitive impairment: MoCa score: score
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main endpoints of the study are the validity and the test-retest reliability of the EMC-test: 1. convergent validity: difference (dB) between the predicted MD (EMC) and the assessed MD (SAP), expressed as delta MD. 2. test-retest reliability: the variability of the predicted MD (dB) between consecutive measurements in the same person | — |
Countries
Netherlands
Outcome results
None listed